Machine Learning Prediction for the Recurrence After Electrical Cardioversion of Patients With Persistent Atrial Fibrillation

被引:1
|
作者
Kwon, Soonil [1 ]
Lee, Eunjung [2 ]
Ju, Hojin [1 ]
Ahn, Hyo-Jeong [1 ]
Lee, So-Ryoung [1 ]
Choi, Eue-Keun [1 ,3 ]
Suh, Jangwon [4 ]
Oh, Seil [1 ,3 ]
Rhee, Wonjong [4 ]
机构
[1] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[2] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA
[3] Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
[4] Seoul Natl Univ, Dept Intelligence & Informat, Seoul, South Korea
关键词
Atrial fibrillation; Electric countershock; Machine learning; Recurrence; SINUS RHYTHM; MAINTENANCE; RISK; EFFICACY;
D O I
10.4070/kcj.2023.0012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: There is limited evidence regarding machine-learning prediction for the recurrence of atrial fibrillation (AF) after electrical cardioversion (ECV). This study aimed to predict the recurrence of AF after ECV using machine learning of clinical features and electrocardiograms (ECGs) in persistent AF patients. Methods: We analyzed patients who underwent successful ECV for persistent AF. Machine learning was designed to predict patients with 1-month recurrence. Individual 12-lead ECGs were collected before and after ECV. Various clinical features were collected and trained the extreme gradient boost (XGBoost)-based model. Ten-fold cross-validation was used to evaluate the performance of the model. The performance was compared to the C-statistics of the selected clinical features. Results: Among 718 patients (mean age 63.5 +/- 9.3 years, men 78.8%), AF recurred in 435 (60.6%) patients after 1 month. With the XGBoost-based model, the areas under the receiver operating characteristic curves (AUROCs) were 0.57, 0.60, and 0.63 if the model was trained by clinical features, ECGs, and both (the final model), respectively. For the final model, the sensitivity, specificity, and F1-score were 84.7%, 28.2%, and 0.73, respectively. Although the AF duration showed the best predictive performance (AUROC, 0.58) among the clinical features, it was significantly lower than that of the final machine-learning model (p < 0.001). Additional training of extended monitoring data of 15-minute single-lead ECG and photoplethysmography in available patients (n=261) did not significantly improve the model's performance. Conclusions: Machine learning showed modest performance in predicting AF recurrence after ECV in persistent AF patients, warranting further validation studies.
引用
收藏
页码:677 / 689
页数:13
相关论文
共 50 条
  • [31] Dabigatran to reduce recurrence of atrial fibrillation after successful electrical cardioversion
    Obst, C.
    Roithinger, F. X.
    Fiedler, L.
    Schoenbauer, R.
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 : S62 - S63
  • [32] A New Electrocardiographic Marker for Recurrence of Atrial Fibrillation After Electrical Cardioversion
    Fujimoto, Yuhi
    Yodogawa, Kenji
    Takahashi, Kenta
    Tsuboi, Ippei
    Yamamoto, Teppei
    Iwasaki, Yu-ki
    Hayashi, Meiso
    Shimizu, Wataru
    CIRCULATION, 2016, 134
  • [33] Analysis of Pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion
    Tveit, A
    Grundtvig, M
    Gundersen, T
    Vanberg, P
    Semb, AG
    Holt, E
    Gullestad, L
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (06): : 780 - 782
  • [34] Burden and Timing of Premature Atrial Contractions After Electrical Cardioversion of Persistent Atrial, Fibrillation Do Not Predict Its Recurrence
    Poci, Dritan
    Abrahamsson, Britt-Marie
    Bergfeldt, Lennart
    Edvardsson, Nils
    CLINICAL CARDIOLOGY, 2008, 31 (10) : 492 - 497
  • [35] Effect of Atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion
    Ozaydin, Mehmet
    Varol, Ercan
    Aslan, Suleyman M.
    Kucuktepe, Zehra
    Dogan, Abdullah
    Ozturk, Mustafa
    Altinbas, Ahmet
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (10): : 1490 - 1493
  • [36] THE STRATEGY OF CATHETER ABLATION FOR PERSISTENT/PERMANENT ATRIAL FIBRILLATION IN THE PATIENTS WITH IMMEDIATE RECURRENCE AFTER CARDIOVERSION
    Inoue, Koichi
    Kurotobi, Toshiya
    Kimura, Ryusuke
    Toyoshima, Yuko
    Ito, Norihisa
    Iwakura, Katsuomi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [37] Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion
    Kim, Sook Kyoung
    Pak, Hui-Nam
    Park, Jae Hyung
    Ko, Kyoung Jeong
    Lee, Jihei Sara
    Choi, Jong Il
    Choi, Dong Hoon
    Kim, Young-Hoon
    EUROPACE, 2009, 11 (12): : 1632 - 1638
  • [38] Role for machine learning in sex-specific prediction of successful electrical cardioversion in atrial fibrillation?
    Vinter, Nicklas
    Frederiksen, Anne Sofie
    Albertsen, Andi Eie
    Lip, Gregory Y. H.
    Fenger-Gron, Morten
    Trinquart, Ludovic
    Frost, Lars
    Moller, Dorthe Svenstrup
    OPEN HEART, 2020, 7 (01):
  • [39] Atorvastatin Given prior to Electrical Cardioversion Does Not Affect the Recurrence of Atrial Fibrillation in Patients with Persistent Atrial Fibrillation Who Are on Antiarrhythmic Therapy
    Demir, Kenan
    Can, Ilknur
    Koc, Fatih
    Vatankulu, Mehmet Akif
    Ayhan, Selim
    Akilli, Hakan
    Aribas, Alpay
    Alihanoglu, Yusuf
    Altunkeser, Bulent Behlul
    MEDICAL PRINCIPLES AND PRACTICE, 2011, 20 (05) : 464 - 469
  • [40] A new piece of puzzle: inflammation in the prediction of recurrence after successful electrical cardioversion in patients with nonvalvular atrial fibrillation Reply
    Aribas, Alpay
    Akilli, Hakan
    Kayrak, Mehmet
    ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2013, 13 (04): : 404 - 405